Federal Register #DEA-1302

DEA final rule updates controlled-substance registration penalty language

The U.S. Drug Enforcement Administration issued a final rule revising controlled-substance registration penalty language. - Government buyer: U.S. Department of Justice, Drug Enforcement Administration (DEA). - Action: Amends 21 CFR 1301.17 to align the regulation with federal law, replacing specified $30,000 fine references with references to title 18 of the United States Code. - Scope: The changes concern pharmacy registration affidavits and obtaining controlled substances through fraudulent registration. - Procurement: This is a regulatory action, not a procurement opportunity; no products, services, quantities, part numbers, OEMs, or vendors are identified.

Description

The Drug Enforcement Administration is amending its regulations at 21 CFR 1301.17 to conform them to the Criminal Law Technical Amendments Act of 2002. The rule replaces specified $30,000 fine references with references to title 18 of the United States Code. The amendments apply to provisions concerning pharmacy registration affidavits and obtaining controlled substances through registration by fraudulent means. This final rule is effective November 2, 2026.

View original listing